DK1899333T3 - Pyrazolopyridinderivater som inhibitorer af beta-adrenerg receptor-kinase 1 - Google Patents

Pyrazolopyridinderivater som inhibitorer af beta-adrenerg receptor-kinase 1

Info

Publication number
DK1899333T3
DK1899333T3 DK06754324T DK06754324T DK1899333T3 DK 1899333 T3 DK1899333 T3 DK 1899333T3 DK 06754324 T DK06754324 T DK 06754324T DK 06754324 T DK06754324 T DK 06754324T DK 1899333 T3 DK1899333 T3 DK 1899333T3
Authority
DK
Denmark
Prior art keywords
inhibitors
beta
adrenergic receptor
receptor kinase
pyrazolopyridine derivatives
Prior art date
Application number
DK06754324T
Other languages
Danish (da)
English (en)
Inventor
Henning Steinhagen
Jochen Huber
Kurt Ritter
Bernard Pirard
Kirsten Bjergarde
Marcel Patek
Martin Smrcina
Linli Wei
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1899333T3 publication Critical patent/DK1899333T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK06754324T 2005-06-27 2006-06-13 Pyrazolopyridinderivater som inhibitorer af beta-adrenerg receptor-kinase 1 DK1899333T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05013774 2005-06-27
PCT/EP2006/005649 WO2007000241A1 (en) 2005-06-27 2006-06-13 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1

Publications (1)

Publication Number Publication Date
DK1899333T3 true DK1899333T3 (da) 2009-06-15

Family

ID=35395578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06754324T DK1899333T3 (da) 2005-06-27 2006-06-13 Pyrazolopyridinderivater som inhibitorer af beta-adrenerg receptor-kinase 1

Country Status (30)

Country Link
US (1) US7910602B2 (xx)
EP (1) EP1899333B1 (xx)
JP (1) JP5010594B2 (xx)
KR (1) KR20080020638A (xx)
CN (1) CN101208340B (xx)
AR (1) AR054514A1 (xx)
AT (1) ATE423118T1 (xx)
AU (1) AU2006264044A1 (xx)
BR (1) BRPI0612320A2 (xx)
CA (1) CA2611296A1 (xx)
CY (1) CY1110464T1 (xx)
DE (1) DE602006005242D1 (xx)
DK (1) DK1899333T3 (xx)
ES (1) ES2322197T3 (xx)
HR (1) HRP20090244T2 (xx)
IL (1) IL188381A0 (xx)
MA (1) MA29498B1 (xx)
MX (1) MX2007015829A (xx)
MY (1) MY139016A (xx)
NO (1) NO20080392L (xx)
NZ (1) NZ564757A (xx)
PL (1) PL1899333T3 (xx)
PT (1) PT1899333E (xx)
RS (1) RS50821B (xx)
RU (1) RU2415855C2 (xx)
SI (1) SI1899333T1 (xx)
TW (1) TW200800982A (xx)
UY (1) UY29632A1 (xx)
WO (1) WO2007000241A1 (xx)
ZA (1) ZA200709853B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200815438A (en) * 2006-06-13 2008-04-01 Bayer Schering Pharma Ag Substituted pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
EP2253618A1 (en) * 2008-02-27 2010-11-24 Takeda Pharmaceutical Company Limited Compound having 6-membered aromatic ring
US9321787B2 (en) * 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2905242C (en) 2013-03-15 2016-11-29 Pfizer Inc. Indole compounds that activate ampk
GB201410815D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
WO2020086503A1 (en) * 2018-10-24 2020-04-30 Bristol-Myers Squibb Company Substituted indole and indazole compounds
EP3870589B1 (en) 2018-10-24 2023-09-06 Bristol-Myers Squibb Company Substituted indole dimer compounds
WO2024137671A1 (en) * 2022-12-20 2024-06-27 Exelixis, Inc. Compounds that inhibit pkmyt1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE355841T1 (de) * 1997-12-13 2007-03-15 Bristol Myers Squibb Co Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer
JP2002020386A (ja) * 2000-07-07 2002-01-23 Ono Pharmaceut Co Ltd ピラゾロピリジン誘導体
WO2003068773A1 (en) * 2002-02-12 2003-08-21 Glaxo Group Limited Pyrazolopyridine derivatives
EA200500322A1 (ru) * 2002-08-07 2005-08-25 Мицубиси Фарма Корпорейшн Соединения дигидропиразолопиридина
WO2004076450A1 (en) * 2003-02-27 2004-09-10 J. Uriach Y Compañia S.A. Pyrazolopyridine derivates

Also Published As

Publication number Publication date
NZ564757A (en) 2009-12-24
MY139016A (en) 2009-08-28
AU2006264044A1 (en) 2007-01-04
CN101208340A (zh) 2008-06-25
EP1899333A1 (en) 2008-03-19
RS50821B (sr) 2010-08-31
MA29498B1 (fr) 2008-05-02
JP5010594B2 (ja) 2012-08-29
ATE423118T1 (de) 2009-03-15
DE602006005242D1 (de) 2009-04-02
RU2415855C2 (ru) 2011-04-10
MX2007015829A (es) 2008-02-22
JP2008543957A (ja) 2008-12-04
AR054514A1 (es) 2007-06-27
US20080227777A1 (en) 2008-09-18
IL188381A0 (en) 2008-04-13
RU2008102970A (ru) 2009-08-10
UY29632A1 (es) 2007-01-31
CN101208340B (zh) 2010-12-22
WO2007000241A1 (en) 2007-01-04
ES2322197T3 (es) 2009-06-17
KR20080020638A (ko) 2008-03-05
PT1899333E (pt) 2009-04-23
ZA200709853B (en) 2008-12-31
US7910602B2 (en) 2011-03-22
BRPI0612320A2 (pt) 2010-11-09
CY1110464T1 (el) 2015-04-29
PL1899333T3 (pl) 2009-07-31
CA2611296A1 (en) 2007-01-04
EP1899333B1 (en) 2009-02-18
HRP20090244T1 (en) 2009-06-30
TW200800982A (en) 2008-01-01
SI1899333T1 (sl) 2009-08-31
HRP20090244T2 (en) 2009-07-31
NO20080392L (no) 2008-02-28

Similar Documents

Publication Publication Date Title
DK1686999T3 (da) Pyrazolderivater som inhibitorer af receptortyrosinkinaser
DK1899333T3 (da) Pyrazolopyridinderivater som inhibitorer af beta-adrenerg receptor-kinase 1
DK2261223T3 (da) Pyrimidinderivater anvendt som PI-3-kinasehæmmere
DK1786799T3 (da) Hidtil ukendte phenylaminopyrimidinderivater som inhibitorer af bcr-abl-kinase
DK2004654T3 (da) Pyrazolopyrimidin derivater til anvendelse som kinase antagonister
NO20082517L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
NO20091423L (no) Pyrimidinderivater og deres anvendelse som kinaseinhibitorer
DK1761505T3 (da) Pyrimidin-urinstof-derivater som kinaseinhibitorer
DK1711481T4 (da) Krystallinsk monohydrat som kinaseinhibitorer
DK1926722T3 (da) Substituerede benzimidazoler som kinaseinhibitorer
DE602005025733D1 (de) Pyrazolopyrimidinderivate als inhibitoren der cyclinabhängigen kinase
DK1943242T3 (da) Piperidin-4-yl-pyridazin-3-ylamin-derivater som hurtigt opløsende antagonister af dopamin-2-receptorer
DK1585749T3 (da) Diazepinoindol-derivater som kinaseinhibitorer
DK1910333T3 (da) Piperidinylsubstituerede isoquinolonderivater som RHO-kinaseinhibitorer
DK1899322T3 (da) Isoquinolin-derivater som hæmmere af Rho-kinase
DK1881976T3 (da) Substituerede amidderivater som proteinkinaseinhibitorer
DK1805164T3 (da) 6-(pyridinyl)-4-pyrimidonderivater som inhibitorer af TAU 1 oroteinkinase
DK2270008T3 (da) 8-Heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-oner som PI-3-kinaseinhibitorer
DK2848610T3 (da) Hæmmere af kinaseaktivitet
DK1778686T3 (da) Triazolopyridinylsulfanylderivater som P38 MAP kinase-inhibitorer
DK1763517T3 (da) Pyrimidinderivater som 11beta-HSD1-inhibitorer
DK1846394T3 (da) Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer
DK1667991T3 (da) Quinazolinderivater som tyrosinkinaseinhibitorer
DK1981875T3 (da) Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
DK2220070T3 (da) 2-benzylpyridazinonderivater som Met-kinaseinhibitorer